ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAA3. A total of 13 filers reported holding ARRAY BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,037,000 | -4.4% | 1,501,000 | 0.0% | 0.01% | -7.7% |
| Q1 2017 | $2,131,000 | -25.7% | 1,501,000 | -26.8% | 0.01% | -23.5% |
| Q4 2016 | $2,868,000 | +18.6% | 2,051,000 | 0.0% | 0.02% | +21.4% |
| Q3 2016 | $2,418,000 | +172.0% | 2,051,000 | +95.1% | 0.01% | +180.0% |
| Q2 2016 | $889,000 | +5.1% | 1,051,000 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $846,000 | +82.7% | 1,051,000 | +110.2% | 0.01% | +66.7% |
| Q4 2015 | $463,000 | – | 500,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 45,000,000 | $53,278,000 | 2.48% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,000,000 | $6,018,000 | 0.85% |
| CSS LLC/IL | 10,546,000 | $12,816,000 | 0.62% |
| Verition Fund Management LLC | 3,400,000 | $4,025,000 | 0.43% |
| Redmile Group, LLC | 4,000,000 | $4,761,000 | 0.38% |
| OAKTREE CAPITAL MANAGEMENT LP | 19,600,000 | $23,231,000 | 0.30% |
| WOLVERINE ASSET MANAGEMENT LLC | 11,139,000 | $13,378,000 | 0.20% |
| LINDEN ADVISORS LP | 2,000,000 | $2,374,000 | 0.11% |
| Fernwood Investment Management, LLC | 90,000 | $106,000 | 0.10% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 5,000,000 | $5,909,000,000 | 0.09% |